Metabolic Syndrome in Psoriasis Patients Increases Cardiovascular Risk
Patients who have psoriasis may be at an increased risk for metabolic syndrome (MetSyn), leading to a higher cardiovascular risk. This new information comes from a study published in the Journal of the American Academy of Dermatology. For the study, researchers from the National Institutes of Health in Bethesda, Maryland, and colleagues examined the impact ...click here to read more